Physician profile
Todd F Dolphin
NPI 1477592954
$1,692.17
in general payments reported to CMS, 2019-2025
16 companies · $780 in 2025
The $780 reported for 2025 was more than what 75% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.05 · 2020: $12.35 · 2021: $83.88 · 2022: $39.96 · 2023: $238 · 2024: $476 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $398.34 | 2024-2025 | Augment Injectable, Easyfuse, Citrefix |
| Kerecis Limited | $348.92 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Convatec INC. | $273.09 | 2023-2025 | |
| Treace Medical Concepts, INC. | $186.08 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $87.62 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $77.90 | 2021-2025 | Stravix Pl, Grafix Pl |
| Abbvie INC. | $70.25 | 2021-2023 | Dalvance, Teflaro |
| Medshape, INC. | $65.53 | 2024 | Lapidus Correction Jig, Right, Dynanail Helix, Washer, 15 Mm |
| Organogenesis INC. | $38.17 | 2023-2025 | Puraply, Via Matrix |
| Integra Lifesciences Corporation | $30.60 | 2019-2021 | |
| Reprise Biomedical, INC. | $27.22 | 2025 | Miro3d |
| Abbott Laboratories | $25.47 | 2019 | |
| Arthrosurface Incorporated | $18.94 | 2019 | |
| Innovation Technologies INC | $16.70 | 2023 | Irrisept |
| Solventum Corporation | $14.99 | 2024 | Prevena, V.A.C. Dermatac, V.A.C.Instill |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Dolphin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.